I n 2014, in the United States, 29,532 patients underwent a solid organ transplant procedure for end-stage lung, liver, kidney, or heart disease as well as other serious conditions. 1,2 Patients undergoing solid organ transplant must take immunosuppressants that lead to increased bone loss and osteoporosis. 1, 3 Therefore, these patients have an increased risk of fragility fractures, especially in the first 6 months after transplant. 3, 4 Because of the use of a combination of glucocorticoids and calcineurin inhibitors and suppression of the immune system, solid organ transplant recipients may be at increased risk for delayed healing and infection after fracture repair surgery.
Contradictory information has been reported on the complication and infection rates in transplant recipients undergoing elective orthopedic surgery (joint arthroplasty). Some studies showed that solid organ transplant recipients and nontransplant patients had similar complica-abstract The complications of emergent or urgent surgery in solid organ transplant recipients are unclear. The goal of this nonrandomized retrospective case study, conducted at a large public university teaching hospital, was to determine the following: (1) 90-day postsurgical complications in solid organ transplant recipients who undergo fracture surgery of the lower extremities; (2) 90-day and 1-year mortality rates for this cohort; (3) correlation of particular postsurgical complications with the 90-day or 1-year mortality rate; and (4) correlation of body mass index with the 90-day or 1-year mortality rate. Subjects included 36 solid organ transplant recipients who underwent surgical treatment for 37 emergent or urgent lower extremity fractures within 72 hours of presentation to the emergency department. Patients were followed for all medical and surgical complications for 90 days and for all-cause mortality for 1 year. Within 90 days of surgery, patients had complications that included acute renal failure (15, 40 .5%), deep venous thrombosis (3, 8 .1%), pulmonary embolus (2, 5.4%), pneumonia (7, 18 .9%), superficial surgical site infection (3, 8 .1%), and nonorthopedic sepsis (4, 10.8%). In addition, 3 (8.1%) and 5 (13.9%) patients died within 90 days and 1 year, respectively. Hospital readmission correlated with a higher 1-year mortality rate (odds ratio, 14.000; P=.016). Higher body mass index correlated with higher 90-day (odds ratio, 1.425; P=.035) and 1-year (odds ratio, 1.334; P=.033) mortality rates. Solid organ transplant recipients with lower extremity fracture have high 90-day and 1-year mortality rates and may have multiple complications within 90 days of treatment. [Orthopedics. 2016; 39(6):e1063-e1069.] tion and infection rates, whereas other reports stated that solid organ transplant recipients had more perioperative complications and higher infection rates. [5] [6] [7] [8] [9] In a study of solid organ transplant recipients undergoing any extramediastinal surgical procedure, the 2 most common complications were postsurgical infection and temporary renal dysfunction (6.9% and 2.6%, respectively). 10 In patients undergoing an emergent procedure, the mortality rate was significantly higher compared with the rate in those undergoing an elective procedure (16.6% vs 1%, respectively). 10 However, only 7 patients underwent an orthopedic procedure. Another study found a complication rate of 7.1% after major orthopedic surgery in heart and lung transplant recipients, whereas the overall mortality rate for any procedure was 2%. 11 Of the surgical procedures, 57 were classified as major orthopedic procedures. A study of traumatic injury in 50 solid organ transplant recipients found no difference in length of stay, incidence of infection, or mortality rate during hospital stay between the transplant and control groups. 12 However, this study included only 17 patients with lower extremity fracture and they were followed only for the duration of the initial hospital stay. 12 This study attempted to answer the following questions: (1) What are the 90-day postsurgical complications (eg, acute kidney injury, transfusion, pneumonia) in solid organ transplant recipients who undergo emergent or urgent surgery for fracture of the lower extremity (within 72 hours of emergency room admission)? (2) What are the 90-day and 1-year mortality rates for solid organ transplant recipients who undergo emergent surgical repair of a lower extremity fracture? (3) Does a particular postsurgical complication correlate with the 90-day or 1-year mortality rate in solid organ transplant recipients who undergo fracture repair surgery? (4) Does higher body mass index correlate with an increased 90-day or 1-year mortality rate in solid organ transplant recipients who undergo fracture repair surgery?
Materials and Methods
This nonrandomized retrospective case series examined lower extremity fractures in patients who had undergone lung, liver, kidney, pancreas, heart, or intestine transplantation and met the study inclusion criteria. The fractures were treated at the study institution between 2000 and 2014. After institutional review board approval was obtained, patient records were examined for all surgical and medical complications and mortality for 90 days and 1 year postoperatively.
Patients were identified in the hospital system with billing queries that used Current Procedural Terminology (CPT) codes that corresponded to lower extremity fracture (pelvis, femur, tibia, lateral/ medial malleolus, or trimalleolar) along with accompanying CPT codes for solid organ transplant (lung, liver, kidney, pancreas, heart, or intestine). All patients included in the study had undergone a successful solid organ transplant procedure at any hospital before being treated for a lower extremity fracture at the study institution. Patients were at least 18 years old and underwent fracture surgery within 72 hours of presentation to the emergency department. Time of emergency department admission was based on the emergency department summary report, when available. If this information was not available, time was based on the time that radiographs were obtained. Anesthesia start time was used as the start time for surgical treatment. Patients were excluded if their records indicated that the fracture occurred more than 72 hours before presentation to the emergency department because this would affect the ability to draw conclusions about the effects of time to surgery. All patients had at least 90 days of follow-up at the study institution. Patients who were initially evaluated at an outside emergency department and then transferred to the institution were included. However, patients were excluded if they had a fracture that was repaired at another hospital or if the fracture occurred before they underwent organ transplant. Patients who were surgically treated for a lower extremity fracture more than 72 hours after injury were excluded from the study. Solid organ transplant recipients who did not have a lower extremity fracture were excluded. The initial CPT query returned 94 patients, and 58 of them were excluded. Of the 94 patients identified, 36 patients were at least 18 years old and met the study criteria. All of these patients had an emergent fracture after a solid organ transplant procedure. One patient had a lower extremity fracture and then had another lower extremity fracture more than 90 days later. These were recorded as 2 independent fracture events for 90-day complication and 90-day mortality data and analyses. However, only the first fracture event was included in 1-year mortality data and analysis because the fractures occurred within 1 year of each other.
The patients underwent open reduction and internal fixation with intramedullary nail and plate/screw fixation or hemiarthroplasty. Clinical follow-up was obtained with retrospective chart review of preoperative and postoperative physician's notes (orthopedic, medical, anesthesia), operative reports, emergency department discharge summaries, clinical examination, laboratory reports, and patient demographics, including age, sex, race, and smoking and drinking behaviors. Other information collected included body mass index, American Society of Anesthesiologists score, estimated blood loss during the index procedure, type of anesthesia, total operative time, need for transfusion, length of hospital stay, immunosuppressive regimen, comorbidity data, current medications, and potentially confounding previous diagnoses. Outcomes were determined by the physician's notes in the chart. Acute kidney injury, pneumonia, anemia, need for transfusion, edema, urinary tract infection, and all other potential complications were recorded if noted in the medical record. Hospital readmission was defined as discharge from the hospital after the emergent fracture procedure followed by readmission at some point in the 90 days after the index procedure.
A total of 36 patients were included, with 37 unique fracture events. The most common fracture site was the trochanteric femur (16, 43.2%), followed by the femoral neck (13, 35 .1%) and tibial shaft (3, 8.1%) (Figure) . Of the study patients, 21 were male and 16 were female. In addition, 34 were white, 2 were African American, and 1 was Asian. Mean body mass index was 27 kg/m 2 (range, 17.5-42 kg/m 2 ). Median age at transplant was 53 years (range, 12-71 years). Median age at fracture was 61 years (range, 20-78 years) ( Table 1) . The total number of transplanted organs was 38 because 1 patient had both a heart and a kidney transplant. Another patient had 2 fracture events, and that patient's demographic information was included twice. Transplants included 18 kidney, 10 liver, 7 heart, 2 single lung, and 1 double lung. The most common comorbidities ( Table 2) were hypertension (24, 65%), dyslipidemia (16, 43%), and diabetes mellitus (16, 43%). Immunosuppressant regimens included prednisone in 32 patients (86.5%; median 24-hour dose, 6.75 mg), tacrolimus in 19 patients (51.4%; median 24-hour dose, 3 mg), cyclosporine in 17 patients (45.9%; median 24-hour dose, 200 mg), mycophenolate mofetil in 15 patients (40.5%; median 24-hour dose, 1000 mg), azathioprine in 4 patients (10.8%; median 24-hour dose, 100 mg), sirolimus in 2 patients (5.4%; median 24-hour dose, 5 mg), and everolimus in 1 patient (2.7%; 24-hour dose, 5.5 mg). Almost all patients were receiving multiple immunosuppressant drugs.
Statistical Analysis
Statistical analysis was conducted with SPSS version 22.0 software (IBM Corp, Armonk, New York). Measures of central tendency, including mean, median, standard deviation, and range, were used to examine continuous variables and identify potential outliers. Percentages and counts were used to classify dichotomous demographic and clinical variables. Binary logistic regression was used as the primary analytical method to examine the effect of potential predictors on the dependent variable. Because of the small sample size and the rarity of the observed outcome events, the potential for small sample bias with the traditional maximum likelihood estimate model was corrected with a penalized likelihood regression model.
results

90-Day Postsurgical Complications
A summary of postoperative complications is shown in Table 3 . The most common 90-day complication was acute renal failure, which occurred in 15 (40.5%) of cases, followed by the need for packed red blood cell transfusion in 14 patients (37.8%). The most common infectious complications were urinary tract infection (9, 24.3%), pneumonia (7, 18.9%), nonorthopedic sepsis (4, 8.1%), and superficial orthopedic surgical site infection (3, 8.1%). Other serious postoperative complications were deep venous thrombosis (3, 8.1%), respiratory failure/arrest/ distress (3, 8.1%), myocardial infarction (1, 2.7%), and multiple organ failure (1, 2.7%), and 6 patients (16.2%) were readmitted to the hospital. Additionally, the study found 1 (2.7%) deep orthopedic surgical site infection, 1 (2.7%) case of orthopedic-related septic shock, and 1 (2.7%) case of aseptic wound dehiscence. Only 1 (2.7%) case of heterotopic os- sification was reported, and no surgical revisions of the initial procedure were reported within 90 days. Of the 37 fractures in solid organ transplant recipients, 36 had at least 1 minor complication, and many patients had multiple complications.
90-Day and 1-Year Mortality Rates
The 90-day all-cause mortality after emergent fracture surgery of a lower extremity in solid organ transplant recipients was 3 (8.1%). The reasons for death within 90 days were septic shock, cerebral hemorrhage, and pulseless electrical activity arrest. The 1-year all-cause mortality was 5 (13.9%) ( Table 3) . The reasons for death within 1 year included the causes of 90-day mortality as well as heart failure as a result of graft rejection and recurrence of cholangiocarcinoma. The 1-year mortality rate reflects the number of patients who died out of the total number of patients (36), not the number of fracture events (37).
Postsurgical Complications and 90-Day and 1-Year Mortality Rates
None of the 90-day postoperative complications were significant predictors of an increased risk of 90-day or 1-year mortality according to univariate regression analysis at a P value of .05. Several postoperative outcomes were grouped for statistical analysis: orthopedic surgery-related infections (superficial surgical site infection and deep surgical site infection), wound complications (superficial surgical site infection and wound dehiscence), and all medical complications. None of these groupings were significant predictors of an increased risk of 90-day or 1-year mortality. However, hospital readmission within 90 days of the index procedure was associated with an increased risk of mortality within 1 year. The odds ratio was 14.0 between hospital readmission and 1-year mortality (beta=2.639; 95% confidence interval, 1.632-120.087; P=.016).
Body Mass Index and Increased 90-Day and 1-Year Mortality Rates
Higher body mass index was predictive of an increased risk of mortality within 90 days after fracture surgery by univariate regression analysis (beta=0.354; odds ratio, 1.425; 95% confidence interval, 1.026-1.981; P=.035). Increased body mass index was also a significant predictor of increased risk of mortality within 1 year after fracture surgery (beta=0.288; odds ratio, 1.334; 95% confidence interval, 1.023-1.740; P=.033). Univariate regression analysis found no statistically significant associations between predictor variables, such as dose of immunosuppressant, American Society of Anesthesiologists score, time from emergency department admission to surgery, sex, age, preoperative albumin level, or preoperative hemoglobin level, and death within 90 days or 1 year at a P value of .05. No predictor variable, including body mass index, was associated with an individual complication within the 90 days after emergent surgery for fracture.
discussion
Immunosuppressive regimens required by solid organ transplant recipients increase the risk of osteoporosis, bone loss, and subsequent fracture. 1, 3, 4 In 2014, 62% of patients who underwent organ transplant were older than 50 years. 2 Studies have shown that those older than 65 years are at particularly high risk for falling and sustaining a fracture. 13, 14 As solid organ transplant recipients age and their fall risk increases, surgeons must consider these factors when making treatment decisions in patients with emergent fractures. Several studies have evaluated the outcomes of elective and emergent procedures in patients after solid organ transplant. [5] [6] [7] [8] 10 However, a study of emergent vs elective procedures in solid organ transplant recipients included only 7 orthopedic procedures. 10 The current study included 37 cases of emergent lower extremity fracture and found that complications such as acute renal failure and packed red blood cell transfusions were common and that this cohort had fairly high 90-day and 1-year mortality rates. Increasing body mass index was associated with increased 90-day and 1-year mortality rates.
90-Day Postsurgical Complications
The novelty of the current study, the first study looking specifically at outcomes in a transplant population after an emergent lower extremity fracture, makes direct comparisons with other studies difficult. However, it is possible to compare the outcomes with those of elective orthopedic procedures. Angermeier et al 5 reported higher rates of superficial surgical site infection (5.1%) and joint revision (13%), but lower rates of deep venous thrombosis (3.4%) and pulmonary embolus (1.7%) than in the current study ( Table 3 ). In the current study, no revision or malunion occurred within 90 days of surgery, suggesting that this cohort had good technical outcomes. Ledford et al 8 found rates of medical complications of 29% and 33% in total hip and total knee arthroplasty, respectively, in solid organ transplant recipients. Klatt et al 7 reported a rate of 39.1% for all complications, with an infectious complication rate of 17.3%. The current study found very high rates of medical complications, with 15 patients (40.5%) having acute renal failure, 14 (37.8%) needing a blood transfusion, 9 (24.3%) having a urinary tract infection, 3 (8.1%) having a superficial surgical site infection, and 3 (8.1%) having nonorthopedic sepsis ( Table 3) .
90-Day and 1-Year Mortality Rates
A study of hip fractures in kidney transplant recipients found a 30-day mortality rate of 2.2%. 15 The patients had comorbid conditions similar to those in the current study, including hypertension (73%), obesity (25%), and diabetes mellitus (39%), but a much higher rate of hemodialysis (84%). 15 With 90 days of follow-up after emergent lower extremity fracture, the mortality rate in the current study was higher, at 8.1%. Studies of mortality after hip fracture in populations with no organ transplant of any kind reported a 90-day mortality rate of 15% and a 1-year mortality rate of 16.4%; however, the study patients were much older (mean age, 84 and 80 years, respectively) than in the current study (59 years). 16, 17 In addition, in the current study, the 1-year mortality rate in patients with an emergent fracture was high, at 13.9%. The large number of comorbidities in solid organ transplant recipients in this study may have contributed to the high mortality and complication rates ( Tables 2-3) .
Correlation of Postsurgical Complications With 90-Day and 1-Year Mortality Rates
Although 15 (40.5%) cases of acute renal failure occurred in the 90 days after surgery, this complication was not significantly associated with 90-day or 1-year mortality at a significance level of .05. No other 90-day complications were indicative of 90-day or 1-year mortality. Grouping of several postsurgical outcomes into surgical infections (superficial surgical site infection and deep surgical site infection), wound complications (superficial surgical site infection and wound dehiscence), and all medical complications (every possible complication included in 1 group) showed no association with 90-day or 1-year mortality rates. Even though the solid organ transplant recipients had a variety of postsurgical complications, none correlated with increased 90-day or 1-year mortality rates. However, univariate regression analysis showed that patients who were readmitted to the hospital within 90 days of fracture repair surgery were 14 times more likely to die within 1 year than those who were not readmitted (95% confidence interval, 1.632-120.087; P=.016). Hospital readmission may be an important postsurgical factor in the prognosis of solid organ transplant recipients who undergo surgery for emergent lower extremity fractures.
Correlation of Body Mass Index With Increased 90-Day and 1-Year Mortality Rates
Univariate regression analysis found an association between increasing body mass index at the time of fracture surgery and death within 90 days postoperatively (odds ratio, 1.425; 95% confidence interval, 1.026-1.981; P=.035). Additionally, an association was found between increasing body mass index at the time of fracture surgery and death within 1 year postoperatively (odds ratio, 1.334; 95% confidence interval, 1.023-1.740; P=.033). To the authors' knowledge, this is the first study to suggest an association between increasing body mass index at the time of surgery and postsurgical mortality in solid organ transplant recipients who have an emergent fracture. Body mass index may be another important factor in the prognosis of these patients.
Limitations
This study had some limitations. First, its retrospective design may introduce selection bias. Second, the authors had to rely on medical records, which makes it difficult to make comparisons with other studies conducted at different institutions. Third, although the sample size exceeded that of most studies of solid organ transplant recipients reported in the orthopedic surgery literature, it is still small (N=37) and has limited power to allow significant statistical conclusions to be drawn. The results of these studies, even when P values suggest significance, should be taken as trends. Despite these limitations, these results provide valuable postoperative information about a unique cohort that currently has few outcomes reported in the literature.
conclusion
Solid organ transplant recipients tend to have many comorbid conditions and may have numerous medical complications in the 90 days after emergent surgery for fracture of the lower extremity. The 90-day and 1-year mortality rates for this group are significant. Patients who are readmitted within 90 days of the index fracture repair surgery may be at increased risk for dying within 1 year. Patients with a higher body mass index may be at increased risk for dying within 90 days and for dying within 1 year after emergent fracture surgery. The high rates of medical complications and mortality should be discussed with patients and their families before surgery. This study emphasizes the need for close monitoring of solid organ transplant recipients after emergent fracture surgery, with particular concern about mortality in patients with a high body mass index and those who are readmitted within 90 days of the index procedure.
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